Physician profile
Robert B Ocasio
NPI 1124054200
$6,476.22
in general payments reported to CMS, 2019-2025
28 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $720 · 2021: $254 · 2022: $706 · 2023: $998 · 2024: $1,500 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,765 · Education: $31.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,765.23 |
| Education | $31.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,269.29 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $685.86 | 2019-2022 | |
| Glaxosmithkline, LLC. | $626.85 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $564.79 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $493.45 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $380.16 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $317.57 | 2019-2025 | Xifaxan |
| Exact Sciences Corporation | $264.59 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $226.39 | 2019-2024 | Veozah, Myrbetriq |
| Amgen INC. | $207.95 | 2019-2025 | Repatha, Krystexxa, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.26 | 2019-2025 | Jardiance, Tradjenta |
| Abbott Laboratories | $132.77 | 2022-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $122.92 | 2024 | |
| Novartis Pharmaceuticals Corporation | $116.28 | 2019-2024 | |
| Arbor Pharmaceuticals, INC. | $104.05 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $96.58 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.03 | 2019 | |
| Sanofi-Aventis U.S. LLC | $89.71 | 2022-2025 | |
| Philips North America LLC | $79.44 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $73.89 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $71.72 | 2025 | General - Pain Management |
| Azurity Pharmaceuticals, INC. | $66.23 | 2023-2025 | Edarbi, Alvesco, Horizant |
| Xeris Pharmaceuticals, INC. | $66.12 | 2023-2024 | Gvoke Hypopen, Keveyis |
| Kowa Pharmaceuticals America, INC. | $51.01 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $30.23 | 2024-2025 | Voquezna |
| Sanofi Pasteur INC. | $26.82 | 2020-2024 | |
| Allergan, INC. | $13.16 | 2019 | |
| Merck Sharp & Dohme LLC | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ocasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.